11/17/2014 - 11:26am

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

11/17/2014 - 10:24am

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

11/17/2014 - 9:54am

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

11/13/2014 - 2:17pm

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

11/13/2014 - 1:59pm

A new analysis released by Avalere Health Thursday found that Medicare Part D prescription drug plans are poised to increase significantly the use of coinsurance in 2015. 

11/12/2014 - 1:15pm

Drug Store News caught up with Rite Aid's Robert Thompson to discuss the impact Vaccine Central will have on raising immunization awareness. 

 

11/10/2014 - 11:40am

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

11/10/2014 - 11:35am

A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 

11/07/2014 - 2:51pm

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.